// App-Quantinova.ai

OP093 : Thienopyridine therapy beyond one year after sirolimus-eluting stent implantation: impact of stent fracture and peri-stent contrast staining

Researchers

Presenter

  • Fuku Y

Principal Investigators

  • Kadota K

  • Hasegawa D

  • Habara S

  • Tada T

  • Tanaka H

  • Goto T

  • Mitsudo K

Medical Centers

  • Kurashiki Central Hospital, Kurashiki, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • sirolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved